HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Raffit Hassan Selected Research
Raffit Hassan Research Topics
Disease
91
Neoplasms (Cancer)
05/2024 - 11/2002
56
Mesothelioma
05/2024 - 11/2002
29
Malignant Mesothelioma
01/2022 - 06/2004
16
Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 11/2002
8
Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 05/2005
8
Lung Neoplasms (Lung Cancer)
01/2022 - 03/2007
7
Disease Progression
01/2022 - 06/2010
7
Adenocarcinoma
01/2020 - 06/2004
7
Adenocarcinoma of Lung
01/2020 - 03/2007
5
Neoplasm Metastasis (Metastasis)
01/2023 - 08/2005
4
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 03/2007
4
Thymoma (Thymic Carcinoma)
10/2019 - 11/2016
4
Carcinoma (Carcinomatosis)
04/2017 - 05/2007
3
Capillary Leak Syndrome
01/2023 - 01/2013
3
Hairy Cell Leukemia
10/2013 - 12/2006
2
Melanoma (Melanoma, Malignant)
05/2024 - 07/2012
2
Ascites
01/2023 - 05/2004
2
Pneumonia (Pneumonitis)
01/2022 - 02/2021
2
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2022 - 01/2018
2
Leukemia
06/2014 - 10/2007
2
Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2007 - 11/2002
2
Ovarian Epithelial Carcinoma
09/2005 - 05/2005
1
Basal Cell Carcinoma (Rodent Ulcer)
05/2024
1
Renal Cell Carcinoma (Grawitz Tumor)
05/2024
1
Sepsis (Septicemia)
01/2022
1
Renal Insufficiency (Renal Failure)
01/2022
1
Atrial Fibrillation
01/2022
1
Arthrogryposis renal dysfunction cholestasis syndrome
01/2022
1
Neutropenia
01/2022
1
Liver Failure
01/2022
1
Fever (Fevers)
02/2021
1
Chills
02/2021
1
Carcinogenesis
12/2020
Drug/Important Bio-Agent (IBA)
67
Mesothelin
IBA
01/2023 - 11/2002
42
Immunotoxins (Immunotoxin)
IBA
01/2023 - 11/2002
17
Monoclonal Antibodies
IBA
01/2018 - 05/2004
15
Proteins (Proteins, Gene)
FDA Link
05/2024 - 05/2005
13
Antigens
IBA
01/2023 - 10/2007
10
Antibodies
IBA
01/2023 - 05/2005
9
amatuximab
IBA
01/2018 - 12/2007
8
Pemetrexed (MTA)
FDA Link
01/2022 - 09/2011
7
Membrane Proteins (Integral Membrane Proteins)
IBA
01/2023 - 08/2005
7
Biomarkers (Surrogate Marker)
IBA
01/2023 - 04/2012
7
Differentiation Antigens
IBA
01/2020 - 06/2004
7
SS1(dsFv)PE38
IBA
04/2016 - 11/2002
6
Cisplatin (Platino)
FDA Link
Generic
01/2021 - 09/2011
6
Membrane Glycoproteins (Membrane Glycoprotein)
IBA
05/2015 - 11/2002
6
Exotoxins
IBA
11/2014 - 05/2004
5
Epitopes
IBA
01/2023 - 09/2005
5
Immune Checkpoint Inhibitors
IBA
01/2022 - 12/2016
5
LMB-100
IBA
11/2020 - 03/2017
5
Immunoconjugates (Immunoconjugate)
IBA
01/2020 - 01/2011
4
Platinum
IBA
01/2022 - 01/2018
4
Surface Antigens (Surface Antigen)
IBA
11/2020 - 01/2006
4
avelumab
IBA
10/2019 - 11/2016
4
Bacterial Toxins
IBA
03/2016 - 02/2010
3
anetumab ravtansine
IBA
01/2022 - 12/2016
3
Asbestos
IBA
12/2020 - 01/2016
3
B7-H1 Antigen
IBA
01/2020 - 01/2019
3
Pentostatin (Nipent)
FDA Link
Generic
06/2014 - 06/2011
3
Cyclophosphamide (Cytoxan)
FDA Link
Generic
06/2014 - 06/2011
3
Vaccines
IBA
06/2014 - 02/2012
3
Paclitaxel (Taxol)
FDA Link
Generic
02/2010 - 08/2006
3
Tumor Biomarkers (Tumor Markers)
IBA
07/2006 - 06/2004
3
Paraffin
IBA
12/2005 - 11/2002
3
Formaldehyde (Formol)
FDA Link
12/2005 - 11/2002
2
RNA (Ribonucleic Acid)
IBA
01/2023 - 01/2020
2
Chimeric Antigen Receptors
IBA
01/2023 - 01/2022
2
Bevacizumab (Avastin)
FDA Link
01/2022 - 09/2011
2
olaparib
IBA
10/2021 - 01/2020
2
Nivolumab
IBA
01/2021 - 01/2020
2
DNA (Deoxyribonucleic Acid)
IBA
12/2020 - 01/2020
2
pembrolizumab
IBA
11/2020 - 01/2020
2
130-nm albumin-bound paclitaxel
IBA
01/2020 - 03/2017
2
Ligands
IBA
01/2019 - 11/2016
2
Histone Deacetylase Inhibitors
IBA
10/2017 - 09/2011
2
Neoplasm Antigens (Tumor Antigens)
IBA
12/2016 - 05/2005
2
T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)
IBA
12/2015 - 06/2014
2
Immunoglobulin G (IgG)
IBA
02/2015 - 05/2005
2
Immunoglobulin Variable Region
IBA
11/2014 - 12/2006
2
Antineoplastic Agents (Antineoplastics)
IBA
06/2014 - 01/2006
2
Cancer Vaccines
IBA
06/2014 - 03/2012
2
Neutralizing Antibodies
IBA
01/2013 - 06/2011
2
Messenger RNA (mRNA)
IBA
11/2012 - 03/2007
2
Gemcitabine
FDA Link
01/2012 - 12/2007
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
01/2023
1
Polysaccharides (Glycans)
IBA
01/2023
1
Vinorelbine (Navelbine)
FDA Link
Generic
01/2022
1
Ubiquitin
IBA
01/2021
1
Ipilimumab
IBA
01/2021
1
Interleukin-12 (IL 12)
IBA
12/2020
1
Interleukin-10 (Interleukin 10)
IBA
12/2020
1
Interleukin-3 (Interleukin 3)
IBA
12/2020
1
Creatinine
IBA
11/2020
Therapy/Procedure
45
Therapeutics
01/2023 - 11/2002
14
Immunotherapy
01/2022 - 08/2005
13
Drug Therapy (Chemotherapy)
01/2022 - 12/2007
2
Radiotherapy
01/2020 - 01/2018
1
Cell- and Tissue-Based Therapy (Cell Therapy)
01/2023
1
Intravenous Administration
01/2022